PHARMACOLOGICALLY BASED PHASE-I TRIALS IN CANCER-CHEMOTHERAPY

被引：12

作者：

NEWELL, DR

机构：

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1994年 / 8卷 / 02期

关键词：

D O I：

10.1016/S0889-8588(18)30172-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：257 / 275

页数：19

共 65 条

[1]

AMES MM, 1990, CANCER RES, V50, P3905

[2]

APPLEIT K, 1991, J MED CHEM, V34, P1925

[3] INDIVIDUAL VARIATION IN THE ACTIVATION AND INACTIVATION OF METABOLIC PATHWAYS OF CYCLOPHOSPHAMIDE [J].

BODDY, AV ;

FURTUN, Y ;

SARDAS, S ;

SARDAS, O ;

IDLE, JR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (22) :1744-1748

[4]

BOVEN E, 1992, CANCER RES, V52, P5940

[5]

Boyd M.K., 1989, CANCER PRINCIPLES PR, V3, P1

[6]

BRODFUEHRER J, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P529

[7] CELL-SIGNALING TARGETS FOR ANTITUMOR DRUG DEVELOPMENT [J].

BRUNTON, VG ;

WORKMAN, P .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (01) :1-19

[8] CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].

CALVERT, AH ;

NEWELL, DR ;

GUMBRELL, LA ;

OREILLY, S ;

BURNELL, M ;

BOXALL, FE ;

SIDDIK, ZH ;

JUDSON, IR ;

GORE, ME ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756

[9] A PHASE-I AND PHARMACOKINETIC STUDY OF DIDOX ADMINISTERED BY 36-HOUR INFUSION [J].

CARMICHAEL, J ;

CANTWELL, BMJ ;

MANNIX, KA ;

VEALE, D ;

ELFORD, HL ;

BLACKIE, R ;

KERR, DJ ;

KAYE, SB ;

HARRIS, AL .

BRITISH JOURNAL OF CANCER, 1990, 61 (03) :447-450

[10] THE ROLE OF INDIVIDUAL HUMAN CYTOCHROMES-P450 IN DRUG-METABOLISM AND CLINICAL-RESPONSE [J].

CHOLERTON, S ;

DALY, AK ;

IDLE, JR .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (12) :434-439

← 1 2 3 4 5 6 7 →